BLRX | “The Buzz” Show: BioLineRX Ltd. (NASDAQ: BLRX) Announces Positive Phase 3 Trial Results

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “BioLineRX Ltd Announces Positive Phase 3 trial Results” BioLineRX Ltd (NASDAQ: BLRX) soared 68% higher in early morning trading from previous close after the company announced positive interim results from a Phase 3 trial of motixafortide.The company said an independent data monitoring committee…Financial Buzz